SRTA
Strata Critical Medical Stock Analysis
AI Rating
- Quality8/10
- Growth↑ 8/10
- Momentum↑ 5/10
SRTA Growth
- Revenue Y/Y↑ 12.69%
- EPS Y/Y↑ 170.00%
- FCF Y/Y↓ -48.74%
SRTA Profitability
- Gross margin ↑ 23.60%
- EPS margin↑ 17.70%
- ROIC↑ 26.00%
SRTA Risk
- Debt / Equity↓ 0.0
- Debt / FCF↓ 0.0
- Interest coverage↓ NA
Strata Critical Medical stock volatility is higher than the overall market. We give it a Great risk rating.